PTGS2 and neoplasm: Ginsenoside Rg3, the main active component of Shenyi capsule, inhibits tumor migration by inhibiting [61] proto-oncogene (C-Myc), cyclooxygenase-2 (COX-2), and matrix metalloproteinase-9 (MMP-9).